Type X collagen is a homotrimer of ml (X) Type X collagen is a short chain, non-fibrillar collagen that consists of three identical oc chains.12 The human octl (X) chains are encoded by a single gene, COLlOAl, which has been cloned, sequenced, and localised to chromosome 6q21-q22.`The homotrimer contains a short triple helical domain flanked by a large, globular carboxyl-terminal (NC1) domain and a short amino-terminal (NC2) domain (fig 1) . The formation of the type X collagen molecule, as with other collagen types, is thought to initiate at the NC 1 domain, the structure of which ensures the correct association and alignment of the ot chains before triple helix formation, which proceeds in an NC 1 to NC2 direction.68 The NC 1 and NC2 domains of the type X collagen molecules are retained extracellularly and participate in interactions between molecules to form supramolecular, hexagonal, lattice structures.9
Abstract
Type X collagen is a homotrimer of ml (X) chains encoded by the COLlOAI gene. It is synthesised specifically and transiently by hypertrophic chondrocytes at sites of endochondral ossification. Point mutations and deletions in the region of the COLlOAl gene encoding the al(X) carboxyl-terminal (NC1) domain have previously been identified in subjects with metaphyseal chondrodysplasia type Schmid (MCDS). To determine whether mutations in other regions of the gene caused MCDS or comparable phenotypes, we used PCR followed by SSCP to analyse the coding and promoter regions of the COLlOAl gene, as well as the intron/exon boundaries of five further subjects with MCDS, one subject with atypical MCDS, and nine subjects with other forms of metaphyseal chondrodysplasia. Using this appproach, three of the subjects with MCDS were found to be heterozygous for the deletions 1864delACTT, 1956delT, and 2029delAC in the region of COLlOAl encoding the NC1 domain. These deletions would lead to alterations in the reading frame, premature stop codons, and the translation of truncated protein products. A fourth subject with MCDS was found to be heterozygous for a single base pair transition, T1894C, that would lead to the substitution of the amino acid residue serine at position 600 by proline within the NCl domain. We did not, however, detect mutations in the coding and non-coding regions of COLlOA1 in one subject with MCDS, the subject with atypical MCDS, and in the nine subjects with other forms ofmetaphyseal chondrodysplasia. We propose that the nature and distribution of mutations within the NC1 domain of COLlOAI causing MCDS argues against the hypothesis that the phenotype arises simply through haploinsufficiency but that an, as yet, unexplained mutation mechanism underlies this phenotype. (JMed Genet 1996; 33:450-457) Key words: mutation; chondrodysplasia; collagen.
Type X collagen is a short chain, non-fibrillar collagen that consists of three identical oc chains.12 The human octl (X) chains are encoded by a single gene, COLlOAl, which has been cloned, sequenced, and localised to chromosome 6q21-q22.`The homotrimer contains a short triple helical domain flanked by a large, globular carboxyl-terminal (NC1) domain and a short amino-terminal (NC2) domain (fig 1) . The formation of the type X collagen molecule, as with other collagen types, is thought to initiate at the NC 1 domain, the structure of which ensures the correct association and alignment of the ot chains before triple helix formation, which proceeds in an NC 1 to NC2 direction.68 The NC 1 and NC2 domains of the type X collagen molecules are retained extracellularly and participate in interactions between molecules to form supramolecular, hexagonal, lattice structures.9
During normal development, type X collagen is exclusively synthesised by hypertrophic chondrocytes of the growth plate during the process of endochondral ossification and its synthesis ceases with the fusion of the growth plates during puberty.'011 Type X collagen synthesis is, however, observed in the adult as a consequence ofthe reinitiation ofthe endochondral ossification process in disease processes such as osteoarthritis and fracture repair.'213 The precise function oftype X collagen is not known but its specific expression within the growth plate has led to the assumption that it has a role in endochondral bone formation.
Genetic approaches to investigate the role of type X collagen in normal development and disease processes have included the generation of type X collagen null mice, ' Family N A sister and brother were examined at the ages of 18 and 12 years, respectively, and found to have a form of short trunk short stature. Radiographs of the sister showed flattening and irregularity of all the vertebral bodies and metaphyseal lesions were evident at the hip and lower end of the ulna, but the epiphyses were normal. She had attained a height of 120 cm. In addition, she had a bulging forehead and slight exophthalmos but no other deformities. The brother had similar short stature but not as marked as his sister and radiographs showed his hips to be normal but with a metaphyseal lesion at the wrist. He, too, had irregular platyspondyly like his sister, as well as the bulging forehead. Their parents were unaffected. The diagnosis was considered to be an unspecified form of spondylometaphyseal chondrodysplasia of autosomal recessive inheritance. The diagnosis was spondylometaphyseal dysplasia.
Family 0
The proband was first examined at the age of 13 months because of proportionate growth retardation that had been noted at birth. Her radiographs showed major irregularities of the femoral head whereas other metaphyses were only mildly affected. The height of the iliac wings was reduced and an ovoid aspect of the vertebrae was observed on a lateral micrograph. At the age of 4 years her height was 91 cm and at this time radiographs showed metaphyseal lesions and shortness of the femoral neck. The proband's mother had an adult height of 142cm. Radiographs of the mother during childhood showed that she had severe coxa vara associated with a slight reduction in the height of the vertebral bodies. She had an osteotomy to correct the hip deformity. The proband's brother was similarly affected. Figure 3 Heteroduplex and SSCP analysis of regions of the COLl OAI gene encoding the NC1 domain. In family A, the E fragments (nucleotides 1933-2204) offamily members Al, A3, and A4 have heteroduplexes above the 271 bp band; this heteroduplex is absent in family member A2. In family B, the B fragment (nucleotides 1219-2019) of family members B2, B3, B4, B5, and B6 have heteroduplexes above the 801 bp band: these heteroduplexes are absent in family member Bl. The position of this mutation was further localised by SSCP analysis to a 243 bp AluI digestion product of the B fragment (results not shown). In family C, single stranded migration changes were evident following denaturation of the E fragments from family member C3 but not from family members Cl and C2. In family D, the position of the mutation in family member D4 was localised to a 243 bp AluI digestion product of the B fragment. Note that the 243 bp band migrates above the 249 bp band on the SSCP gel Using this approach, SSCP changes and heteroduplexes that did not result from the presence of previously identified polymorphisms or sequence variants3032 were identified within the COLlOAl gene of the probands from families A, B, C, and D (fig 3) . The SSCP changes and heteroduplexes were in each instance located to the region of the gene encoding the NC 1 domain of otl(X) (nucleotides 1654-2136 and amino acids 520-680) and were present in other affected members of the families but absent in unaffected family members (fig 3) . The migration changes were more precisely located to the E fragment (nucleotides 1933-2204) of affected members of families A and C and to the 243 bp AluI digestion product (nucleotides 1777-2019) of the B fragment (nucleotides 1218-2019) of affected family members from families B and D.
SEQUENCE ANALYSIS OF FOUR NOVEL MUTATIONS WITHIN THE NC1 DOMAIN OF THE

(X) CHAIN
Sequence analysis was used to identify the mutations of the probands of families A to D (fig 4) . From double stranded sequencing in both the 5' and 3' direction, proband C3 was found to be heterozygous for the deletion of the nucleotide T at position 1956, which would alter the codon for the proline at position 620 from CCT to CCG and introduce a premature stop codon at the following amino acid, position 621. It was necessary to clone the PCR amplified DNA from probands A3, B4, and D4 to determine the precise nature and extent of their mutations. Proband A3 was found to be heterozygous for the deletion of two base pairs, AC, at nucleotide positions 2029-2030, which would alter the reading frame from amino acid 645 and introduce a premature termination codon at amino acid position 647. Proband B4 was found to be heterozygous for the deletion of four base pairs, ACTT at nucleotide positions 1864-1867, which would alter the reading frame from amino acid 590 and introduce a premature termination codon at amino acid position 604. Proband D4 was found to be heterozygous for a single base pair transition of T to C at nucleotide position 1994 which would lead to the substitution of a serine for a proline at amino acid position 600. Concurrent sequence analysis of the region of the COLlOAl gene encoding the entire NC1 domain of the proband E3 did not show any novel sequence changes.
SEGREGATION ANALYSIS OF COLlOAl POLYMORPHISMS
The COL1 OA1 genotypes ofmembers offamilies E, F, M, N, and 0 were determined for previously identified polymorphisms.'032 The polymorphisms segregated with the phenotype in families F and 0, were concordant with the phenotype in family M, were non-informative in family E, and were discordant with the phenotype in family N (fig 2) . 
Discussion
We have identified a further four mutations that cause MCDS. A total of 21 different mutations causing this condition have now been identified (table) and in each instance these mutations occur in the region of the gene encoding the NC1 domain (amino acids 520-680) of the ocl (X) chain. Further, the mutations that have been identified so far cluster in the more carboxyl-terminal half of this domain with the most 5' mutation altering the reading frame of amino acid 590 and the most 3' mutation introducing a premature termination signal at amino acid position 665. This latter mutation causes the truncation of the chain by only 16 amino acids (that is, one tenth of the NC1 domain). In all instances, the mutations result in the same phenotype indicating that, irrespective of the nature of the mutation, the molecular consequences are likely to be the same. T1867C  C591R  19  G1880A  G595E  22  T1885C  Y597H  22  T1888G  Y598D  18  T1894C  S600P  This paper (family D)  T1937C  L614P  18  T1947A  N617K  22  G1949T  G618V  21  1952delC Frameshift at 620 19 I procollagen) have, however, been found to cause osteogenesis imperfecta type I (OI I), the mildest form of this inherited bone disease, which has been likened to MCDS in that it is caused by production of half normal amounts of type I procollagen.334 A recent report of mutations that caused OI I described two single nucleotide substitutions that altered 5' donor splice sites, a point mutation within an exon that created a premature termination codon, and four small deletions that caused translational frameshifts and new termination codons downstream of the mutations sites. 35 In these instances, reduced steady state levels of mRNA from the mutant COLlAl alleles were observed in both total and nuclear RNA extracts isolated from fibroblasts from affected family members such that the mutant COLlAl alleles were effectively "null" alleles. Six of the mutations occurred in regions of the gene encoding the triple helical domain and one in the region of the gene encoding the telopeptide. The kinds of mutations causing OI type I should be detected readily using the methods that we and others have used to identify mutations within COLl OA1 in persons from MCDS, yet similar mutations causing MCDS have not been found.
The phenotypes of the type X null mice'4 and the type X transgenic mice15 also argue against haploinsufficiency as the mutation mechanism underlying MCDS. Mutant mice homozygous for the type X collagen null mutation were viable and fertile and had apparently normal long bone growth and development. In addition, the absence of type X did not appear to have any effect on mineralisation or the distribution of other ECM components (osteopontin, osteocalcin, and type II collagen). The absence of a phenotype in the type X null mice was a surprising finding and seriously questioned whether half normal amounts of type X collagen could produce the phenotype of persons with MCDS. Further, the absence of a phenotype in the type X null mice has also brought into doubt whether the phenotype of the type X collagen transgenic mice was the result of a dominant negative mutation mechanism as had been previously proposed. ' 
